Cambiar Investors LLC Raises Position in Maximus, Inc. (MMS)

Cambiar Investors LLC boosted its stake in Maximus, Inc. (NYSE:MMS) by 2.6% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 63,145 shares of the health services provider’s stock after purchasing an additional 1,582 shares during the period. Cambiar Investors LLC owned about 0.10% of Maximus worth $4,073,000 at the end of the most recent quarter.

A number of other large investors also recently modified their holdings of MMS. Teachers Advisors LLC lifted its stake in Maximus by 5.9% in the 1st quarter. Teachers Advisors LLC now owns 119,967 shares of the health services provider’s stock valued at $7,462,000 after purchasing an additional 6,696 shares during the last quarter. Dimensional Fund Advisors LP lifted its stake in Maximus by 3.2% in the 1st quarter. Dimensional Fund Advisors LP now owns 632,118 shares of the health services provider’s stock valued at $39,318,000 after purchasing an additional 19,788 shares during the last quarter. AQR Capital Management LLC lifted its stake in Maximus by 0.9% in the 1st quarter. AQR Capital Management LLC now owns 40,868 shares of the health services provider’s stock valued at $2,542,000 after purchasing an additional 361 shares during the last quarter. Fox Run Management L.L.C. bought a new position in Maximus in the 2nd quarter valued at approximately $326,000. Finally, Capstone Asset Management Co. lifted its stake in Maximus by 1.1% in the 2nd quarter. Capstone Asset Management Co. now owns 7,052 shares of the health services provider’s stock valued at $442,000 after purchasing an additional 80 shares during the last quarter. 97.55% of the stock is owned by institutional investors and hedge funds.

MMS has been the subject of several research reports. Zacks Investment Research raised shares of Maximus from a “hold” rating to a “buy” rating and set a $73.00 price objective for the company in a research note on Wednesday, October 4th. Robert W. Baird assumed coverage on shares of Maximus in a research note on Sunday, September 3rd. They issued a “neutral” rating for the company. Canaccord Genuity decreased their price target on shares of Maximus from $62.00 to $61.00 and set a “hold” rating for the company in a research report on Friday, November 10th. Maxim Group set a $66.00 price target on shares of Maximus and gave the company a “hold” rating in a research report on Thursday, August 3rd. Finally, BidaskClub cut shares of Maximus from a “hold” rating to a “sell” rating in a research report on Monday, July 24th. Two equities research analysts have rated the stock with a sell rating and seven have issued a hold rating to the stock. The company has an average rating of “Hold” and an average price target of $63.00.

In other news, CEO Richard A. Montoni sold 29,203 shares of the stock in a transaction on Thursday, August 17th. The shares were sold at an average price of $60.38, for a total transaction of $1,763,277.14. Following the completion of the sale, the chief executive officer now directly owns 549,215 shares in the company, valued at $33,161,601.70. The transaction was disclosed in a filing with the SEC, which is available at this link. Also, General Counsel David Francis sold 2,000 shares of the stock in a transaction on Friday, August 18th. The stock was sold at an average price of $58.89, for a total transaction of $117,780.00. Following the sale, the general counsel now owns 13,716 shares of the company’s stock, valued at $807,735.24. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 104,103 shares of company stock valued at $6,509,460. Corporate insiders own 3.10% of the company’s stock.

Shares of Maximus, Inc. (MMS) traded up $0.20 during midday trading on Wednesday, reaching $64.78. 285,200 shares of the company’s stock traded hands, compared to its average volume of 363,109. Maximus, Inc. has a 1 year low of $51.74 and a 1 year high of $66.96. The firm has a market cap of $4,189.45, a PE ratio of 20.78, a P/E/G ratio of 2.06 and a beta of 1.32.

The firm also recently declared a quarterly dividend, which will be paid on Thursday, November 30th. Shareholders of record on Wednesday, November 15th will be given a $0.045 dividend. This represents a $0.18 annualized dividend and a yield of 0.28%. The ex-dividend date of this dividend is Tuesday, November 14th. Maximus’s dividend payout ratio (DPR) is currently 5.66%.

ILLEGAL ACTIVITY NOTICE: “Cambiar Investors LLC Raises Position in Maximus, Inc. (MMS)” was originally posted by Sports Perspectives and is the sole property of of Sports Perspectives. If you are accessing this story on another website, it was stolen and reposted in violation of United States & international copyright & trademark legislation. The correct version of this story can be read at https://sportsperspectives.com/2017/11/15/cambiar-investors-llc-raises-position-in-maximus-inc-mms.html.

About Maximus

MAXIMUS, Inc provides business process services (BPS) to government health and human services agencies. The Company operates through three segments: U.S. Federal Services, Health Services and Human Services. The U.S. Federal Services segment provides BPS and program management for large government programs, independent health review and appeals services for both the United States Federal Government, and state-based programs and technology solutions for civilian federal programs.

Institutional Ownership by Quarter for Maximus (NYSE:MMS)

Receive News & Ratings for Maximus Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Maximus Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply